Blockbuster gene study gives breast cancer hope
This article was originally published in Clinica
In what has been described as "probably the most important paper on breast cancer genetics since the cloning of BRCA2 in 1995", a multinational research group has identified four genes that can increase the risk of developing breast cancer. The 45,000-patient study, led by Cancer Research UK, and carried out at 15 centres is claimed to be the world's first large scale "whole genome search" for faulty genes that increase breast cancer risk.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.